Lista de obras - Ciriana Orabona - Dominio Público Uruguay

A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression

artículo científico publicado en 2012

A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice

artículo científico publicado en 2003

AhR-Mediated, Non-Genomic Modulation of IDO1 Function

artículo científico publicado en 2014

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

artículo científico publicado en 2014

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.

artículo científico publicado en 2004

CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig.

artículo científico publicado en 2005

CTLA-4-Ig regulates tryptophan catabolism in vivo.

artículo científico publicado en 2002

Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.

artículo científico publicado en 1997

Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ

artículo científico publicado en 2015

Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients

artículo científico publicado en 2020

Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12.

artículo científico publicado en 2005

Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes

artículo científico publicado en 2014

High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.

artículo científico publicado en 2013

IL-12 Acts Directly on DC to Promote Nuclear Localization of NF-κB and Primes DC for IL-12 Production

scientific article published on 01 September 1998

IL-12 INDUCES SDS-STABLE CLASS II αβ DIMERS IN MURINE DENDRITIC CELLS

artículo científico publicado en 2000

IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality

artículo científico publicado en 2011

Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex

artículo científico publicado en 1999

Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes

artículo científico publicado en 2007

Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.

artículo científico publicado en 2014

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

scientific journal article

LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism

artículo científico publicado en 2014

Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.

artículo científico publicado en 2005

Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes

artículo científico publicado en 2018

Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy

artículo científico publicado en 2015

Modulation of tryptophan catabolism by regulatory T cells.

artículo científico publicado en 2003

Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation

artículo científico publicado en 2020

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

artículo científico publicado en 2007

Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.

artículo científico publicado en 2015

The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections

The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity

artículo científico publicado en 2012

Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.

artículo científico publicado en 2005

Tryptophan catabolism generates autoimmune-preventive regulatory T cells

artículo científico publicado en 2006

Lista de obras de Ciriana Orabona

A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression

A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice

AhR-Mediated, Non-Genomic Modulation of IDO1 Function

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.

CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig.

CTLA-4-Ig regulates tryptophan catabolism in vivo.

Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells.

Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ

Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients

Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12.

Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes

High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway.

IL-12 Acts Directly on DC to Promote Nuclear Localization of NF-κB and Primes DC for IL-12 Production

IL-12 INDUCES SDS-STABLE CLASS II αβ DIMERS IN MURINE DENDRITIC CELLS

IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality

Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex

Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes

Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism

Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells.

Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes

Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy

Modulation of tryptophan catabolism by regulatory T cells.

Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.

The circadian control of tryptophan metabolism regulates the host response to pulmonary fungal infections

The p50 subunit of NF-κB orchestrates dendritic cell lifespan and activation of adaptive immunity

Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.

Tryptophan catabolism generates autoimmune-preventive regulatory T cells